My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
The European Journal of Psychiatry
Print version ISSN 0213-6163
Abstract
MARTIN VAZQUEZ, Mª José and JIMENO BELTRAN, Teresa. Neuroleptic malignant syndrome: Possible relationship between neuroleptic treatment and smoking cessation. Eur. J. Psychiat. [online]. 2007, vol.21, n.4, pp.287-291. ISSN 0213-6163.
We report the case of M., a schizophrenic patient who was treated with high doses of antipsychotics for a long time allowing him to be stable for years. He then decided to give up smoking and two weeks later he suffered a syndrome diagnosed as Neuroleptic Malignant Syndrome with somatic complications. This caused his death two months after the start of the symptoms. We discuss the implications of smoking cessation in the origin of the syndrome due to a lower metabolism of psychotropic medications, which previously had been well tolerated. We conclude that it is important to take into account the smoking and caffeine intake of these patients, as well as other metabolic inductor or inhibitor drugs.
Keywords : Neuroleptic malignant syndrome; Smoking cessation; Drug metabolism; Electroconvulsive therapy; Atypical neuroleptic malignant syndrome.
![](/img/en/iconPDFDocument.gif)